GWSA
ARCT icon

Global Wealth Strategies & Associates’s Arcturus Therapeutics ARCT Stock Holding History

Global Wealth Strategies & Associates’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100
Closed -$1.7K – 475
2024
Q4 		$1.7K Hold
100
– – ﹤0.01% 336
2024
Q3 		$2.32K Hold
100
– – ﹤0.01% 289
2024
Q2 		$2.44K Hold
100
– – ﹤0.01% 259
2024
Q1 		$3.38K Hold
100
– – ﹤0.01% 247
2023
Q4 		$3.15K Hold
100
– – ﹤0.01% 232
2023
Q3 		$2.56K Buy
+100
New +$3.08K ﹤0.01% 249

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Global Wealth Strategies & Associates's ARCT Position: Q1 2025 in Review

Global Wealth Strategies & Associates sold out of Arcturus Therapeutics (ARCT) in Q1 2025, closing a stake of 100 shares — an estimated $1.7K sold.

Global Wealth Strategies & Associates first reported a position in ARCT in Q3 2023 and held it in 6 quarters. The position peaked at $3.38K in Q1 2024. 144 funds tracked by Wall St. Rank hold ARCT as of Q1 2025.

  • Global Wealth Strategies & Associates reported no remaining Arcturus Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Global Wealth Strategies & Associates sold 100 Arcturus Therapeutics shares in Q1 2025, an estimated $1.7K.
  • Global Wealth Strategies & Associates first reported a position in Arcturus Therapeutics in Q3 2023 and held it in 6 quarters.
  • Global Wealth Strategies & Associates's Arcturus Therapeutics position peaked at $3.38K in Q1 2024.
  • 144 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2025.

Based on Global Wealth Strategies & Associates's 13F filing for Q1 2025, filed 2 Apr 2025.